U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07268586) titled 'Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention' on Nov. 01.
Brief Summary: People with acute inferior wall myocardial infarction will be given an intravenous drug called atropine that increases the heart rate to check if it prevents heart rhythm disturbances during performing coronary intervention
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Myocardial Infarction
Intervention:
DRUG: Intravenous atropine immediately before wire crossing during primary percutan...